Framework · Contracts Finder
BTH25-027 Oncotype DX Breast Recurrence Score test
Groups 1 related procurement, worth £194.4k combined.
- 1
- Member contracts
- £194.4k
- Combined value
- 1
- Buyers
BTH25-027 Oncotype DX Breast Recurrence Score test is a UK public-sector framework or programme that groups 1 related procurement worth £194.4k combined. The member contracts and call-offs below are run by 1 participating buyer.
Details
- Source
- Contracts Finder
- Member contracts
- 1
- Combined value
- £194,400
- First activity
- 11 Apr 2025
- Latest activity
- 11 Apr 2025
- Participating buyers
- 1
Member procurements
Contracts and call-offs grouped under this framework.
| Procurement | Buyer | Stage | Value |
|---|---|---|---|
| BTH25-027 Oncotype DX Breast Recurrence Score test | Bradford Teaching Hospitals NHS Foundation Trust | Award | £194.4k |
Participating buyers
FAQs about this framework
What is the "BTH25-027 Oncotype DX Breast Recurrence Score test" framework?
It groups 1 related UK public procurement worth £194,400 combined, published via Contracts Finder.
Which buyers use this framework?
1 buyer participate, including Bradford Teaching Hospitals NHS Foundation Trust.
When is this framework active?
Recorded activity runs from 11 Apr 2025 to 11 Apr 2025.
Get ahead on framework opportunities
Enable tracks frameworks and their call-offs across UK public procurement so you can position before the next mini-competition. Talk to us.
Get in touch with Enable